Sedaciön y analgesia de pacientes crïticos en ventilaciön mecânica. Tienen utilidad los alfa-2 agonistas?

Medicina Intensiva

Volumn 23, Issue 2, 1999, Pages 59-61

  Chamorro, C ^a   Romera Y, M A ^a   Martinez Melgar, J L ^b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Servicios de Medicina Intensiva   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748097627     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ledingham IM. Walt I. Influence of sedation on mortality in critically-ill multiple trauma patients. Lancet 1983; 1: 1.270.
2. Rapold HJ, Follath F, Sco11o-Lavi//ari G. Ritz R. Diarepam: Hazardous sedation of ventilated patients. Intensive Care Med 1983; 9: 2IX.
3. Liebeskind JC. Pain can kill. Pain 1991 ; 44: 3-4.
4. Anand KOS. Phil D, Hickey PR. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. N Engl J Med 1992: 326: 1-9.
5. Hansen-Flaschen JH. BraJ.insky S. Basile C, Lanken PN. use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national Survey. JAMA 1991; 266: 2.870-2.875.
6. Sanchex-l/quierdo Riera JA. Alted Löpez F. Sa Borges M. Sandiumenge Camps A. Sedoanalgesia-relajacion en la Unidad de Cuidados Intensivos. Situaciön en Espafia. Med Intensiva 1998; 22: 1-6.
7. Carrasco G, Molina R. Costa J, Soler JM, Cabre L. Propofol vs midaJ.olam in short, medium, and long term sedation of critically ill patients. Chest 1993: 103: 557-564.
8. Chamorro C. de Latorre FJ. Montero A, Sdnche/-lzquierdo JA. Jareno A. Moreno JA, et al. Comparative study of propofol versus mida/olam in the sedation of critically ill patients: Result of a prospective, randomiJ.ed. multicenter trial. Crit Care Med 1996: 24: 932-939.
9. Barrientos-Vega R. SancheJ.-Soria MM. Morales Garci'a C. Robas-Gômez A. Cuena-Boy R. Ayensa-Rincôn A. Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and cost. Crit Care Med 1997; 25: 33-40.
10. Shapiro BA. Warren J. Egol AB, Greenbaum DM, Jacobi J. Nasraway SA, et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: An executive summary. Crit Care Med 1995:23: 1.596-1.600.
11. Chamorro C. Romera MA. Estecha MA, Rubio JJ. Sedaciôn en UCI. Nuevos iarmacos para nuevas tendencias. Med Intensiva 1994; 18: 164-172.
12. Osborne RJ, Joel SP. Slevin ML. Morphine intoxication in renal failure: the role of morphine-glucuronide. Br Med J 1986: 292: 1.548-1.549.
13. Aitkenhead AR. Willats SM, Park GR. Collins CH. Ledingham IM. Pepperman ML. et al. Comparison of propotbl and mida/olam for sedation in critically ill patients. Lancet 1989: 2: 704-708.
14. Snellen F. Lauwers P. Demeyere R. Bytterhier G, Van Aken H. The use of mida/olam versus propotbl for short-term sedation following coronary artery bypass grafting. Intensive Care Med 1990; 16: 312-316.
15. Kress JP. O'Connor MF. Pohlman AS. Oison D. Lavoie A. Toledano A. Hall JB. Sedation of critically ill patients during mechanical ventilation. A comparison of propoibl and mida/olam. Am J Respir Crit Care Med 1996; 153: 1.012-1.OIS.
16. Pohlman AS, Simpson KP. Hall JB. Continuos intravenous infusion of lorazepam and midazolam in the treatment of acute agitation syndromes during mechanical ventilatory support. Crit Care Med 1994:22: 1.241-1.247.
17. Hoey LH, Vance-Bryan K. Clarens DM. Wright DH. Konstantinides FN. Guay DRP. Lora/epain stability in parenteral solutions for continuous intravenous administration. Ann Pharmacother 1996:30:343-346.
18. Chamorro C. A cost-effective and volume-sparing strategy for continuous ben/odiacepine infusions. Crit Care Med 1997: 2?: 1.932-1.933.
19. Chamorro C. Borrallo JM. Molina JM, Romera MA. Mas M. Mosquera JM. Administration secuencial mida/olam-propofol en sedaciones proloncadas de pacicnles crfticos. Med Intensiva 1994; !8(Supl 1 ): S284.
20. Carrasco G. Cabré LL. Sobrepere G. Costa J. Molina R. Cruspinera A. Lacasa C. Synergistic sedation with propotbl and mida/olam in intensive care patients after coronary artery bypass grafting. Crit Care Med 1998: 26: 844-851.
21. Lavifieta Romano E. Alberdi Odrio/ola F. Arcega Fernande/ I. Luque Le/cano O. Romo Jiméne/ E. Garcia Alonso J. Sfn drome de deprivation tras sedaciön prolongada en UC1. Med Intensiva 1997:21:269-273.
22. Cammarano WB. Pittet JF. Weit/ S. Schlobohm RM. Marks JD. Acute withdrawal syndrome related to the administration of analgesis and sedative medications in adult intensive care unit patients. Crit Care Med 1988: 26: 676-684.
23. Tryba M. Kulka P, ZenJ. M. Sympathetic hyperactivity syndromes in ventilated patients. En: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine 1993. Berlin-Heidelberg: Springer-Verlag. 1993: 529-539.
24. M are M. Tranquilli W. Alpha-2 adrenoreceptor agonist: defining the role in clinical anesthesia. Anesthesioloey 1991: 74: 581-605.
25. Bernard JM. Hommeril JL. Passuti N. Pinaud M. Postoperative analgesia by intravenous clonidine. Anesthesiology 1991: 75: 577-582.
26. Bohrer H. Bach A. Layer M. Werning P. Clonidine as a sedative adjunt in intensive care. Intensive Care Med 1990; 16: 265-266. "
27. Yam PC. Forbes A. Kox WJ. Clonidine in the treatment of alcohol withdrawal in the intensive care unit. Br J Anaesth 1992: 68: 106-108.
28. Chamorro C. Borrallo JM. Rui/ de Luna R. Melgar JL. Mosquera JM. Alpha-2 agonist to smooth ineffective sedation in ICU patients. Ottawa: 7th World Congress of intensive and Critical Care Medicine. 1997: S493.
29. Kulka PJ. Tryba M. Zen/ M. Preoperative a,-adrenergic receptor agonist prevent the deterioration of renal function after cardiac surgery: Results of a randomi/ed. controlled trial. Crit Care Med 1996: 24: 947-952.
30. Merles N. Goeters C. Kuhmann M, Zander JF. Postoperative alpha 2-adrenergic stimulation attenuates protein eatabolism. Anesth Analg 1996: 82: 258-263.